Harrow HROW
NASDAQ HROW
$37.79 -0.06 (-0.15%)
As of: Sep 9, 2026 · 1:50 PM EDT

Harrow (HROW) Profit After Tax (2010 - 2026)

Harrow (HROW) posted Profit After Tax of -$17.3 million for Q2 2026, up 37.43% on a QoQ basis from -$27.6 million in Q1 2026, and down 445.75% year-over-year from $5.0 million in Q2 2025.

Analysis

Harrow (HROW) Profit After Tax (2010 - 2026) Analysis & Trends

Harrow has reported Profit After Tax for 17 years, with the latest figure at -$17.3 million in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 445.75% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$37.2 million, a 263.96% decrease from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 70.6% from the prior year.
  • Profit After Tax was -$17.3 million for Q2 2026 at Harrow, up from -$27.6 million in the prior quarter.
  • The five-year high for Profit After Tax was $6.8 million in Q4 2024, with the low at -$27.6 million in Q1 2026.
  • Average Profit After Tax over 5 years is -$5.9 million, with a median of -$5.3 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Profit After Tax tumbled 1223.5% in 2022, then jumped 177.17% in 2025.
  • Over 5 years, Profit After Tax stood at $1.1 million in 2022, then sank by 967.11% to -$9.1 million in 2023, then soared by 174.08% to $6.8 million in 2024, then decreased by 2.23% to $6.6 million in 2025, then slumped by 360.64% to -$17.3 million in 2026.
  • The last three Profit After Tax figures came in at -$17.3 million (Q2 2026), -$27.6 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 5.53 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 3.62 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 3.26 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -248.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 438.21 Mn
7 Revolution Medicines 44.23 Bn 44.23 Bn - -644.37 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 333.00 Mn
10 Harrow 1.42 Bn 1.33 Bn 50.36 Mn -17.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.27 Mn
Mar 31, 2026 -27.60 Mn
Dec 31, 2025 6.63 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -13.57 Mn
Dec 31, 2023 -9.15 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -6.64 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 -6.24 Mn
Mar 31, 2022 -2.44 Mn
Dec 31, 2021 -7.42 Mn
Sep 30, 2021 -8.33 Mn